Regorafenib in Refractory Advanced Biliary Tract Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Multi-Institutional Phase 2 Trial of Regorafenib in Refractory Advanced Biliary Tract Cancer
Cancer 2020 May 26;[EPub Ahead of Print], RD Kim, HK Sanoff, AS Poklepovic, H Soares, J Kim, J Lyu, Y Liu, AB Nixon, DW KimFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.